Leerink Partners Reiterates Market Perform Rating for 2seventy bio (NASDAQ:TSVT)
Leerink Partners reiterated their market perform rating on shares of 2seventy bio (NASDAQ:TSVT – Free Report) in a research report sent to investors on Tuesday,Benzinga reports. The brokerage currently has a $5.00 target price on the stock, down from their previous target price of $9.00. Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares […]
